Daewoong Pharmaceutical Co., Ltd Stock Price

KOSE:A069620 Community·₩1.6t Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

A069620 Share Price Performance

₩139,700.00

-12000.00 (-7.91%)

₩139,700.00

-12000.00 (-7.91%)

₩139,700.00

Sat, 8 Nov 25

Share Price₩139,700.00

A069620 Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Snowflake Analysis

Undervalued with mediocre balance sheet.

2 Risks

3 Rewards

View Full Analysis

Daewoong Pharmaceutical Co., Ltd Key Details

Last Reported Earnings

Jun 30, 2025

Next Reporting Earnings

n/a

: 6.53k
: 51.68%
: 5.05%
: 80.3%

View Full Analysis

About A069620

Founded: 1945
Employees: 1644
CEO: Chang-Jae Lee
WebsiteView website: www.daewoong.com

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.